Biotech News Roundup: TrumpRx Launches, Roivant's Breakthrough, and More

The biotech industry has been abuzz with activity in recent days, with major developments in drug pricing, rare disease treatment, and gene therapy. Here's a roundup of the latest news: **TrumpRx Launches** President Trump on Thursday night launched TrumpRx, a website aimed at lowering drug prices. According to reports, the platform will allow users to compare prices of prescription medications and find cheaper alternatives. While the move has been touted as a step towards making healthcare more affordable, critics have raised concerns about the effectiveness of the platform in addressing the root causes of high drug prices. (Source: STAT+: Pharmalittle) **Roivant's Breakthrough** In a significant breakthrough, Roivant's immune drug has shown promising results in treating a rare skin disease. In a small trial, the drug significantly outperformed placebo in clearing lesions caused by the disease. The results have been hailed as a major milestone in the treatment of the condition, which affects thousands of people worldwide. (Source: STAT+: Roivant immune drug significantly outperformed placebo in treating rare skin disease) **Comings and Goings** The pharmaceutical industry has seen a flurry of comings and goings in recent days. From new hires to departures, promotions, and transfers, the industry is witnessing a period of significant change. Among the notable moves is the appointment of a new CEO at a major biotech firm. (Source: STAT+: Up and down the ladder: The latest comings and goings) **IPOs and Gene Therapy** The biotech industry has also seen a surge in IPOs, with several companies going public in recent weeks. Meanwhile, gene therapy has been making headlines, with several companies working on developing new treatments using the technology. However, challenges remain, including the high cost of gene therapy and the need for more research into its long-term effects. (Source: STAT+: IPOs, GLP-1s, and challenges with a gene therapy) **What is a 'Natural' Dye?** In other health news, the concept of "natural" dyes has been making headlines. But what exactly does it mean for a dye to be natural? The answer is not as straightforward as it seems. While some dyes may be derived from natural sources, others may be processed using synthetic methods. The debate highlights the need for greater transparency in the labeling of food and cosmetic products. (Source: What is a ‘natural’ dye, anyway?) **Hims & Hers Selling Compounded Wegovy Pill** Telehealth company Hims & Hers has started selling a compounded version of the popular weight loss medication Wegovy. The move has raised eyebrows, with some critics arguing that the company is profiteering from the sale of a medication that is not yet widely available. (Source: STAT+: Pharmalittle) As the biotech industry continues to evolve, one thing is clear: the next few months will be crucial in shaping the future of healthcare. With major developments in drug pricing, rare disease treatment, and gene therapy, the industry is poised for significant growth and innovation.